[Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
Spiridonova
M G
MG
Stepanov
V A
VA
Puzyrev
V P
VP
D000483:Alleles; D000818:Animals; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000235:genetics*; D014644:Genetic Variation; D006710:Homocysteine / Q000009:adverse effects; D006801:Humans; D020138:Hyperhomocysteinemia / Q000201:enzymology / Q000235:genetics; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009154:Mutation; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D011110:Polymorphism, Genetic; D044469:Racial Groups / Q000235:genetics
D006710:Homocysteine; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)